Reviva Pharmaceuticals Holdings, Inc. (RVPH) SEC Filings — 2025
16 SEC filings for Reviva Pharmaceuticals Holdings, Inc. (RVPH) in 2025.
Filings
- Reviva Pharmaceuticals Files 8-K with Corporate Updates — 8-K · Dec 23, 2025
- Reviva Pharmaceuticals Holdings, Inc. DEFA14A Filing — DEFA14A · Dec 5, 2025
- Reviva Narrows Losses, Boosts Cash Amidst Ongoing Funding Needs — 10-Q · Nov 13, 2025
- Reviva Pharma Seeks Share Increase, Reverse Split Ahead of Key Vote — DEF 14A · Nov 4, 2025
- Reviva Pharmaceuticals Faces Delisting Notice — 8-K · Oct 17, 2025
- Reviva Pharmaceuticals Files 8-K — 8-K · Sep 26, 2025
- Reviva Pharmaceuticals Files 8-K with Material Agreement Details — 8-K · Sep 19, 2025
- Reviva Narrows Losses, Raises Capital Amidst Going Concern Warning — 10-Q · Aug 14, 2025
- Reviva Pharmaceuticals Files 8-K with Material Agreement Details — 8-K · Jun 26, 2025
- Reviva Pharmaceuticals Changes Auditors to EisnerAmper LLP — 8-K · Jun 6, 2025
- Reviva Pharmaceuticals Files 8-K — 8-K · Jun 2, 2025
- Reviva Pharmaceuticals Files 8-K — 8-K · May 30, 2025
- Reviva Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Reviva Pharmaceuticals Files 2024 10-K — 10-K · Apr 3, 2025
- Reviva Pharmaceuticals Files 8-K on Financials — 8-K · Mar 31, 2025
- Reviva Pharmaceuticals Announces Board and Officer Changes — 8-K · Feb 18, 2025